The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...
Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback